Aion Therapeutic Acquires Toppen Health Inc.
December 15, 2023
Aion Therapeutic Inc. completed the acquisition of all outstanding shares of Toppen Health Inc., a Sanford, Florida-based manufacturer of water filtration systems, pursuant to share purchase agreements dated October 2023. The transaction was satisfied by the issuance of CAD $10,000,000 in common shares and includes a potential US $2,000,000 earn-out tied to revenue targets; Toppen operates a 7,500 sq-ft manufacturing facility and has eight employees.
- Buyers
- Aion Therapeutic Inc.
- Targets
- Toppen Health Inc.
- Sellers
- Toppen shareholders
- Industry
- Manufacturing
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Eilean Therapeutics Acquires Ness Therapeutics
March 4, 2024
Biotechnology
Eilean Therapeutics LLC acquired Ness Therapeutics Inc in an all-equity transaction to obtain Ness’s preclinical PTPN2 inhibitor program. The acquisition expands Eilean’s immuno-oncology pipeline and capabilities in small-molecule inhibitors targeting resistance mechanisms in hematologic and solid malignancies.
-
PAI Partners Acquires Apleona from EQT for ~€1.6bn
December 6, 2020
Industrial Services
PAI Partners has agreed to acquire Apleona Group GmbH from EQT (EQT VII) for approximately EUR 1.6 billion. Apleona, headquartered in Neu-Isenburg, Germany, is a leading European technical and integrated facility management provider with more than 20,000 employees and a strong position in the DACH region; PAI said it will pursue further consolidation and growth both organically and via M&A.
-
Nordson Corporation to Acquire Atrion Corporation
May 28, 2024
Medical Devices
Nordson Corporation has entered into a definitive agreement to acquire Atrion Corporation for $460.00 per share in cash, representing an aggregate enterprise value of approximately $800 million. The acquisition expands Nordson's medical portfolio into infusion and cardiovascular therapies and is expected to close prior to Nordson's fiscal year-end 2024, subject to regulatory and stockholder approvals.
-
Shionogi Acquires Tetra Therapeutics
May 26, 2020
Biotechnology
Shionogi & Co., Ltd. agreed to acquire clinical-stage biopharmaceutical company Tetra Therapeutics, giving Shionogi global rights to Tetra's portfolio including BPN14770. The deal, announced May 26, 2020, is valued at up to $500 million in milestone and contingent payments.
-
Ionis Pharmaceuticals to Acquire Remaining Stake in Akcea Therapeutics
August 31, 2020
Biotechnology
Ionis Pharmaceuticals agreed to acquire the approximately 24% of Akcea Therapeutics it does not already own for $18.15 per share in cash, implying a fully diluted transaction value of about $500 million. The deal will be executed via a tender offer followed by a second-step merger, and Ionis expects to complete the transaction in Q4 2020 to consolidate Akcea's pipeline, commercial products and cash while realizing cost synergies.
-
Softheon Acquires NextHealth Technologies
June 30, 2022
Healthcare Services
Softheon has acquired NextHealth Technologies, an AI-powered SaaS healthcare analytics platform, to accelerate its AI and care-management capabilities for health plans. The deal brings NextHealth’s team and technology into Softheon and results in NextHealth investors Norwest Venture Partners and TT Capital Partners becoming investors in Softheon to support combined growth.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.